Baker, A. L., Hides, L. and Lubman, D. I. (2010). Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review. The Journal of Clinical Psychiatry, 71, 247–354. doi: 10.4088/JCP.09r05119gry.
Black, P. and Joseph, L. J. (2014). Still dazed and confused: midlife marijuana use by the baby boom generation. Deviant Behavior, 35, 822–841. doi: 10.1080/01639625.2014.889994.
Blazer, D. G. and Wu, L.-T. (2009). The epidemiology of substance use and disorders among middle aged and elderly community adults: national survey on drug use and health. American Journal of Geriatric Psychiatry, 17, 237–245.
Bobadilla, L., Vaske, J. and Asberg, K. (2013). Dopamine receptor (D4) ploymorphis is related to comorbidity between marijuana abuse and depression. Addictive Behaviors, 38, 2555–2562. doi: 10.1016/j.addbeh.2013.05.014.
Brady, J. E. and Li, G. (2014). Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999–2010. American Journal of Epidemiology, 179, 692–699. doi: 10.1093/aje/kwt327.
Bricker, J. B.
et al. (2007). Does occasional marijuana use impact anxiety and depression treatment outcomes?: results from a randomized effectiveness trial. Depression and Anxiety, 24, 392–398.
Carter, M. W. and Reymann, M. R. (2014). ED use by older adults attempting suicide. American Journal of Emergency Medicine, 32, 535–540. doi: 10.1016/j.ajem.2014.02.003.
Chen, H., Cohen, P. and Chen, S. (2010). How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies. Communications in Statistics-Simulation and Computation, 39, 860–864.
DiNitto, D. M. and Choi, N. G. (2011). Marijuana use among older adults in the U.S.A.: user characteristics, patterns of use, and implications for intervention. International Psychogeriatrics, 23, 732–741. doi: 10.1017/S1041610210002176.
Dowling, G. J., Weiss, S. R. and Condon, T. P. (2008). Drugs of abuse and the aging brain. Neuropsychopharmacology, 33, 209–218.
Fairman, B. J. and Anthony, J. C. (2012). Are early-onset cannabis smokers at an increased risk of depression spells?
Journal of Affective Disorders, 138, 54–62. doi: 10.1016/j.jad2011.12.031.
Frishman, W. H., Del Vecchio, A., Sanal, S. and Ismail, A. (2003a). Cardiovascular manifestations of substance abuse part 1: cocaine. Heart Disease, 5, 187–201.
Frishman, W. H., Del Vecchio, A., Sanal, S. and Ismail, A. (2003b). Cardiovascular manifestations of substance abuse: part 2: alcohol, amphetamines, heroin, cannabis, and caffeine. Heart Disease, 5, 253–271.
Ge, B., Zhang, Z. and Zuo, Z. (2014). Updates on the clinical evidenced herb-warfarin interactions. Evidence Based Complementary and Alternative Medicine, 2014, 957362. doi: 10.1155/2014/957362.
Inter-university Consortium for Political and Social Research. (2012). National Survey on Drug Use and Health, 2012: Codebook. ICPSR 34933. Ann Arbor, MI.
Hall, W. and Degenhardt, L. (2009). Adverse health effects of non-medical cannabis use. The Lancet, 374, 1383–1391. doi: 10,1016/S0140-6736(09)61037-0.
Hall, W. and Degenhardt, L. (2014). The adverse effects of chronic cannabis use. Drug Testing and Analysis, 6, 39–45. doi: 10.1002/dta.1506.
Harrell, F., Lee, K. L. and Mark, D. B. (1996). Tutorial in biostatistics multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statistics in Medicine, 15, 361–387.
Hosmer, D. W., Lemeshow, S. and Sturdivant, R. X. (2013). Applied Logistic Regression, 3rd edn, New York, NY: Wiley.
Johnson, K. H., Bazargan, M. and Cherpitel, C. J. (2001). Alcohol, tobacco, and drug use and the onset of type 2 diabetes among inner-city minority patients. Journal of American Board Fam Pract, 14, 430–436.
Lev-Ran, S., Roerecke, M., Le Foll, B., George, T. P., McKenzie, K. and Rehm, J. (2014). The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychological Medicine, 44, 797–810. doi: 10.1017/S0033291713001438.
Lutchmansingh, D., Pawar, L. and Savici, D. (2014). Legalizing cannabis: a physician's primer on the pulmonary effects of marijuana. Current Respiratory Care Reports, 3, 200–205.
Mauro, P. M., Canham, S. L., Martins, S. S. and Spira, A. P. (2015). Substance-use coping and self-rated health among US middle-aged and older adults. Addictive Behaviors, 42, 96–100. doi: 10.1016/j.addbeh.2014.10.031.
Mechoulam, R. (2012). Cannabis–a valuable drug that deserves better treatment. Mayo Clinic Proceedings, 87, 107–109. doi: 10.1016/j.mayocp.2011.12.002.
Mechoulam, R. and Parker, L. A. (2013). The endocannabinoid system and the brain. Annual Review of Psychology, 64, 21–47. doi: 10.1146/annurev-psych-113011-143739.
et al. (2010). Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. Journal of Forensic Science, 55, 1209–1217. doi: 10.1111/j.1556-4029.2010.01441.x.
Otten, R. and Engels, R. C. (2013). Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene. Addiction Biology, 18, 826–835. doi: 10.1111/j.1369-1600.2011.00380.x.
Pacek, L. R., Martins, S. S. and Crum, R. M. (2013). The bidirectional relationships between alcohol, cannabis, co-occuring alcohol and cannabis use disorders with major depressive disorder: results from a national sample. Journal of Affective Disorders, 148, 188–195. doi: 10.1016/j.jad.2012.11.059.
Pacher, P., Bátkai, S. and Kunos, G. (2006). The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacology Review, 58, 389–462.
Pedersen, W. (2008). Does cannabis use lead to depression and suicidal behaviours? A population-based longitudinal study. Acta Psychiatrica Scandinavica, 118, 395–403.
Price, C., Hemmingsson, T., Lewis, G., Zammit, S. and Allebeck, P. (2009). Cannabis and suicide: longitudinal study. The British Journal of Psychiatry, 195, 492–497. doi: 10.1192/bjp.bp.109.065227.
Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163, 1344–1364. doi: 10.1111/j.1476-5381.2011.01238.x.
Shi, Y. (2014). At high risk and want to quit: marijuana use among adults with depression or serious psychological distress. Addictive Behaviors, 39, 761–767. doi: 10.1016/j.addbeh.2013.12.013.
Thomas, G., Kloner, R. A. and Rezkalla, S. (2014). Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. American Journal of Cardiology, 113, 187–190. doi: 10.1016/j.amjcard.2013.09.042.
van den Elsen, G. A.
et al. (2014). Efficacy and safety of medical cannabinoids in older subjects: a systematic review. Ageing Research Reviews, 14, 56–64. doi: 10.1016/j.arr.2014.01.007.
van Ours, J. C., Williams, J., Fergusson, D. and Horwood, L. J. (2013). Cannabis use and suicidal ideation. Journal of Health Economics, 32, 524–537. doi: 10.1016/j.jhealeco.2013.02.002.
et al. (2004). The risk for mild kidney function decline associated with illicit drug use among hypertensive men. American Journal of Kidney Disease, 43, 629–635.
Volkow, N. D., Baler, R. D., Compton, W. M. and Weiss, S. R. (2014). Adverse health effects of marijuana use. The New England Journal of Medicine, 370, 2219–2227. doi: 10.1056/NEJMra1402309.
Wu, L.-T. and Blazer, D. G. (2014). Substance use disorders and psychiatric comorbidity in mid and later life: a review. International Journal of Epidemiology, 43, 304–317. doi:10.1093/ije/dyt173.